Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
PRNewswire - October 30, 2009
Ignacius Cisneros, of Odessa, Texas, has agreed to serve on the advisory board of Alumni and business leaders.
In inviting Cisneros to participate, Dr. Jaime Chahin, Dean of the College of Applied Arts stated, "Your experience, expertise, and professional networks will assist the College in achieving our educational goals...Your professional input and guidance are of utmost importance regarding our College's vision and academic strategies."
The University has become well acquainted with Mr. Cisneros because of the sponsored research projects between his company, CISNE Enterprises and TSU.
Recently, Texas State University conducted a year long battery of successful in vitro tests to determine cancer chemotherapeutic and anti-retroviral effects of the ALKA-V6 compound on cancer cells and the HIV virus.
University researchers concluded, "The unique electrochemical and structural composition of ALKA-V6 indicates that it may provide an alternative basis for control of cancer cell growth and virus survival. However, this implication is based solely on in-vitro results and end-point in-vivo evaluations are imperative." The University and CISNE are discussing additional research activities.
University faculty researchers, Drs. Reed Richardson and Diraj Vattem plan to present their findings and publish results in scientific journals in 2010.
Orizon Research Institute of Odessa, Texas is the international distributor of ALKA V-6. Orizon remains committed to providing the ALKA-V6 compound to the general public as an affordably priced nutritional supplement that can be purchased directly from the company web site. The research studies conducted at Texas State are also available on the Orizon Research web site at www.orizonresearch.com.
CONTACT: Orizon Research, LLC, 1-877-367-7770, media@orizonresearch.com; or Jayme Blaschke of University New Service, Texas State University, +1-512-245-2180
Source: Orizon Research Institute
CONTACT: Orizon Research, LLC, 1-877-367-7770, media@orizonresearch.com; or Jayme Blaschke of University New Service, Texas State University, +1-512-245-2180
Web Site: http://www.orizonresearch.com/
091030
PR091040
Copyright © 2009 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .